About John McDonough
John McDonough advises Aces Diagnostics and serves as an Aces director. He is chief executive officer and board chairman at Sunbird Bio, and he chairs Cytrellis Biosystems.
He also serves on the boards of Solace Therapeutics and BioPorto Diagnostics. From 2007 through January 2020, he was founding president and chief executive officer of T2 Biosystems.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name John McDonough in the role, so the role may have started earlier or lasted longer.
ACES Diagnostics, Inc. Current
Scientific and Strategic Advisor, director
2026 – Present · Paradise Valley, AZ
A blood test that combines Lyme disease biomarkers with machine learning to support earlier detection.
Cytrellis Biosystems, Inc. Current
Treasurer and Secretary, director
Chairman of the Board
2015 – Present · Woburn, MA
ST
Solace Therapeutics Current
Director
BD
BioPorto Diagnostics Current
Director
TI
T2 Biosystems, Inc.
Founding President and Chief Executive Officer (2007 – 2020)
Director
2007 – 2021 · Public company (TTOO)
Key Colleagues at Startups
The people John McDonough works with at each company, as listed on that company's latest Form D.
ACES Diagnostics, Inc. · Form D, Oct 27, 2026
.png)
Tammy Crawford
Founder & Chief Executive Officer, director
KS
Kim Sablich
Director
LG
Linda Giampa
Director
TS
Todd Snowden
Founder & Chief Business Officer, director
Cytrellis Biosystems, Inc. · Form D, Dec 31, 2024
KC
Keith Crandell
Director
FM
Fred Aslan, MD
Director
FM
Frederick Beddingfield III, MD
Director
MP
Michael Peterson
Director
SunBird Bio, Inc. · Form D, May 12, 2023
AC
Alexandra Cantley
Director
SL
Stanley Lapidus
Director
YW
Yingmin Wang
Director
HS
Huilin Shao
Director
SK
Steve Kafka
Director